Gluthion

Gluthion is a pharmaceutical product containing the active ingredient glutathione sodium, supplied in an injectable form for intramuscular or intravenous administration. It is marketed in the European Union and classified as an antioxidant nutritional supplement. The preparation is intended to support cellular antioxidant capacity by replenishing intracellular glutathione levels, thereby helping to mitigate oxidative stress in various clinical contexts and may be used under medical supervision.

Gluthion is employed in clinical practice primarily to address conditions associated with reduced glutathione levels and heightened oxidative stress. It may be considered as an adjunct in the management of certain metabolic, hepatic, and immune‑related disorders where antioxidant support is desired. - Support of hepatic detoxification processes in liver disorders. - Adjunctive therapy for patients with oxidative stress‑related metabolic conditions. - Aid in maintaining cellular redox balance during chemotherapy. - Potential benefit in chronic fatigue or low‑energy syndromes. - Support for immune system function in immunocompromised individuals.

Gluthion may cause a range of side effects, most of which are mild and transient, while rare serious reactions require immediate medical attention. Common: - Mild injection site pain or erythema. - Transient headache or dizziness. - Nausea or mild gastrointestinal discomfort. - Temporary metallic taste. - Low-grade fever. - Muscle cramps. Serious: - Severe allergic reaction (anaphylaxis) with rash, swelling, breathing difficulty. - Acute hemolysis in patients with G6PD deficiency. - Significant hypotension following rapid intravenous infusion. - Pulmonary edema in susceptible individuals. - Cardiac arrhythmias. - Renal impairment.

When considering Gluthion, healthcare professionals should evaluate patient history and clinical status to minimize risks and ensure appropriate use. Specific conditions and concurrent therapies may influence safety, requiring careful assessment before initiation. - Assess for known hypersensitivity to glutathione or formulation excipients. - Screen for glucose‑6‑phosphate dehydrogenase (G6PD) deficiency prior to administration. - Use caution in patients with asthma or severe respiratory disorders. - Monitor blood pressure during rapid intravenous infusion. - Adjust dose in individuals with renal or hepatic impairment. - Avoid use during pregnancy and lactation unless clearly indicated.

Gluthion may interact with certain medications or substances, potentially altering efficacy or safety profiles. Awareness of these interactions helps clinicians manage therapy and reduce adverse outcomes. Avoid: - Concurrent use with high‑dose vitamin C, which may reduce glutathione effectiveness. - Simultaneous administration of nitroglycerin, increasing risk of severe hypotension. - Co‑administration with other antioxidant injections without monitoring. Use with caution: - Chemotherapeutic agents (e.g., cisplatin) – may affect drug resistance. - Anticoagulants – monitor for enhanced bleeding tendency. - Immunosuppressants – observe for altered immune response. - Diuretics – watch for electrolyte disturbances.